Prevalence of restless legs syndrome among leprosy patients: a hospital based study.

Padhi T, Pradhan S.

Lepr Rev. 2014 Sep;85(3):218-23.

Circadian variation of fatigue in paralytic poliomyelitis and postpolio syndrome: just fatigue or masked restless legs syndrome?

Romigi A, Placidi F, Evangelista E, Desiato MT.

Arq Neuropsiquiatr. 2014 Jun;72(6):475-6. No abstract available.

Evaluation of temperament and character features as risk factors for depressive symptoms in patients with restless legs syndrome.

Altunayoglu Cakmak V, Gazioglu S, Can Usta N, Ozkorumak E, Ayar A, Topbas M, Boz C.

J Clin Neurol. 2014 Oct;10(4):320-7. doi: 10.3988/jcn.2014.10.4.320.

Evaluation of restless legs syndrome in fibromyalgia syndrome: an analysis of quality of sleep and life.

Civelek GM, Ciftkaya PO, Karatas M.

J Back Musculoskelet Rehabil. 2014;27(4):537-44. doi: 10.3233/BMR-140478.

Association between restless legs syndrome and migraine: a population-based study.

Zanigni S, Giannini G, Melotti R, Pattaro C, Provini F, Cevoli S, Facheris MF, Cortelli P, Pramstaller PP.

Eur J Neurol. 2014 Sep;21(9):1205-10. doi: 10.1111/ene.12462.

Putting the legs back into restless legs syndrome: new evidence for the microvascular hypothesis.

St Louis EK, Ulfberg J.

Neurology. 2014 May 27;82(21):1850-1. doi: 10.1212/WNL.0000000000000462. No abstract available.

The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome.

Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Calleja M, Plaza-Nieto JF, Pilo-de-la

Sleep Med. 2014 Feb;15(2):266-8. doi: 10.1016/j.sleep.2013.08.800.

Investigational approaches to therapies for restless legs syndrome.

de Biase S, Merlino G, Lorenzut S, Valente M, Gigli GL.

Expert Opin Investig Drugs. 2014 Jun;23(6):847-56. doi: 10.1517/13543784.2014.907793. Review.

Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep.

Jordan I, Murray D.

Neurology. 2014 Jan 28;82(4):372-3. doi: 10.1212/01.wnl.0000443817.83968.a7. No abstract available.

Restless legs syndrome: pathophysiology and treatment.

Ondo WG.

Curr Treat Options Neurol. 2014 Nov;16(11):317. doi: 10.1007/s11940-014-0317-2.

Restless legs syndrome status as a predictor for lower physical function.

Zhang C, Li Y, Malhotra A, Ning Y, Gao X.

Neurology. 2014 Apr 8;82(14):1212-8. doi: 10.1212/WNL.0000000000000284.

Restless legs syndrome and central nervous system gamma-aminobutyric acid: preliminary associations with periodic limb movements in sleep and restless leg syndrome symptom severity.

Winkelman JW, Schoerning L, Platt S, Jensen JE.

Sleep Med. 2014 Oct;15(10):1225-30. doi: 10.1016/j.sleep.2014.05.019.

Abdominal paresthesia resembling restless legs syndrome successfully treated with iron supplement therapy: a case report.

Suzuki M, Yamada K, Kanamori T, Konno C, Konno M, Takahashi S, Aramaki O, Takayama T, Uchiyama M.

J Neurol Sci. 2014 Jan 15;336(1-2):291-2. doi: 10.1016/j.jns.2013.10.042. No abstract available.

Sleep disorders: A review of the interface between restless legs syndrome and iron metabolism.

Daubian-Nosé P, Frank MK, Esteves AM.

Sleep Sci. 2014 Dec;7(4):234-7. doi: 10.1016/j.slsci.2014.10.002. Review.

A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.

Sun Y, van Valkenhoef G, Morel T.

Curr Med Res Opin. 2014 Nov;30(11):2267-78. doi: 10.1185/03007995.2014.946124.